logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12122819 B1

PDFFull Text
Date of Patent:
Oct. 22, 2024

Filed:

Feb. 10, 2022

Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin a5 variant

Applicant:

Silver Creek Pharmaceuticals, Inc., San Francisco, CA (US);

Inventors:

Laura D. J. Antipov, Oakland, CA (US);

Shawdee Eshghi, Oakland, CA (US);

Kristopher M. Kuchenbecker, Phoenix, AZ (US);

Bjorn L. Millard, Orinda, CA (US);

Matthew D. Onsum, El Cerrito, CA (US);

Andrea D. Nickerson, San Francisco, CA (US);

Timothy R. Stowe, San Francisco, CA (US);

Yan Zhang, San Francisco, CA (US);

Assignee:

Silver Creek Pharmaceuticals, Inc., San Francisco, CA (US);

Attorneys:

Greenberg Traurig, LLP

Natalie Salem

David J. Dykeman

Primary Examiner:

Robert S Landsman

Int. Cl.
CPC ...
C07K 14/65 (2006.01); A61K 38/00 (2006.01); C07K 14/47 (2006.01); C07K 14/765 (2006.01);
U.S. Cl.
CPC ...
C07K 14/65 (2013.01); C07K 14/47 (2013.01); C07K 14/765 (2013.01); A61K 38/00 (2013.01); C07K 2319/035 (2013.01); C07K 2319/33 (2013.01); C07K 2319/75 (2013.01);
Abstract

Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.

Find Patent Forward Citations

Antipov, Laura D. J.. (2024). Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin a5 variant (U.S. Patent No. 12122819). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12122819

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…